282 related articles for article (PubMed ID: 24412705)
1. Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses.
Xiao J; Zhai H; Yao Y; Wang C; Jiang W; Zhang C; Simard AR; Zhang R; Hao J
Neuroscience; 2014 Mar; 262():156-64. PubMed ID: 24412705
[TBL] [Abstract][Full Text] [Related]
2. MS-275, an histone deacetylase inhibitor, reduces the inflammatory reaction in rat experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Schluesener HJ
Neuroscience; 2010 Aug; 169(1):370-7. PubMed ID: 20451583
[TBL] [Abstract][Full Text] [Related]
3. Curcumin ameliorates rat experimental autoimmune neuritis.
Han F; Luo B; Shi R; Han C; Zhang Z; Xiong J; Jiang M; Zhang Z
J Neurosci Res; 2014 Jun; 92(6):743-50. PubMed ID: 24482305
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline attenuates peripheral inflammation in rat experimental autoimmune neuritis.
Yi C; Zhang Z; Wang W; Zug C; Schluesener HJ; Zhang Z
Neurochem Res; 2011 Nov; 36(11):1984-90. PubMed ID: 21656035
[TBL] [Abstract][Full Text] [Related]
5. AUY954, a selective S1P(1) modulator, prevents experimental autoimmune neuritis.
Zhang ZY; Zhang Z; Zug C; Nuesslein-Hildesheim B; Leppert D; Schluesener HJ
J Neuroimmunol; 2009 Nov; 216(1-2):59-65. PubMed ID: 19804913
[TBL] [Abstract][Full Text] [Related]
6. Distribution of inducible nitric oxide synthase and tumor necrosis factor-alpha in the peripheral nervous system of Lewis rats during ascending paresis and spontaneous recovery from experimental autoimmune neuritis.
De La Hoz CL; Castro FR; Santos LM; Langone F
Neuroimmunomodulation; 2010; 17(1):56-66. PubMed ID: 19816058
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells.
Li XL; Dou YC; Liu Y; Shi CW; Cao LL; Zhang XQ; Zhu J; Duan RS
Cell Immunol; 2011; 271(2):455-61. PubMed ID: 21889126
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.
Zhang ZY; Zhang Z; Fauser U; Schluesener HJ
J Cell Mol Med; 2009 Feb; 13(2):341-51. PubMed ID: 18400050
[TBL] [Abstract][Full Text] [Related]
9. Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2/hemoxygenase-1 pathway by altering the balance of M1/M2 macrophages.
Han R; Xiao J; Zhai H; Hao J
J Neuroinflammation; 2016 May; 13(1):97. PubMed ID: 27142843
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats.
Zou LP; Pelidou SH; Abbas N; Deretzi G; Mix E; Schaltzbeerg M; Winblad B; Zhu J
J Neuroimmunol; 1999 Aug; 98(2):168-75. PubMed ID: 10430050
[TBL] [Abstract][Full Text] [Related]
11. Programmed Death Ligand 1 Plays a Neuroprotective Role in Experimental Autoimmune Neuritis by Controlling Peripheral Nervous System Inflammation of Rats.
Ding Y; Han R; Jiang W; Xiao J; Liu H; Chen X; Li X; Hao J
J Immunol; 2016 Nov; 197(10):3831-3840. PubMed ID: 27798164
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): suppression of IFN-gamma and TNF-alpha and enhancement of IL-10.
Di Marco R; Khademi M; Wallstrom E; Muhallab S; Nicoletti F; Olsson T
J Autoimmun; 1999 Sep; 13(2):187-95. PubMed ID: 10479387
[TBL] [Abstract][Full Text] [Related]
13. The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain-Barré syndrome.
Jiao H; Ren H
Drug Des Devel Ther; 2018; 12():3817-3824. PubMed ID: 30464413
[TBL] [Abstract][Full Text] [Related]
14. Lovastatin attenuates nerve injury in an animal model of Guillain-Barré syndrome.
Sarkey JP; Richards MP; Stubbs EB
J Neurochem; 2007 Mar; 100(5):1265-77. PubMed ID: 17286627
[TBL] [Abstract][Full Text] [Related]
15. Resistance and susceptibility to experimental autoimmune neuritis in Sprague-Dawley and Lewis rats correlate with different levels of autoreactive T and B cell responses to myelin antigens.
Zhu J; Zou LP; Bakhiet M; Mix E
J Neurosci Res; 1998 Nov; 54(3):373-81. PubMed ID: 9819142
[TBL] [Abstract][Full Text] [Related]
16. Mitigated Tregs and augmented Th17 cells and cytokines are associated with severity of experimental autoimmune neuritis.
Wang X; Zheng XY; Ma C; Wang XK; Wu J; Adem A; Zhu J; Zhang HL
Scand J Immunol; 2014 Sep; 80(3):180-90. PubMed ID: 24910360
[TBL] [Abstract][Full Text] [Related]
17. The effect of treatment with crotapotin on the evolution of experimental autoimmune neuritis induced in Lewis rats.
Castro FR; Farias AS; Proença PL; de La Hoz C; Langone F; Oliveira EC; Toyama MH; Marangoni S; Santos LM
Toxicon; 2007 Mar; 49(3):299-305. PubMed ID: 17145071
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous system.
Abbas N; Zou LP; Pelidou SH; Winblad B; Zhu J
Autoimmunity; 2000 Sep; 32(2):93-9. PubMed ID: 11078155
[TBL] [Abstract][Full Text] [Related]
19. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects.
Zhang Z; Zhang ZY; Schluesener HJ
J Immunol; 2009 Sep; 183(5):3081-91. PubMed ID: 19675162
[TBL] [Abstract][Full Text] [Related]
20. Neurophysiological changes in demyelinating and axonal forms of acute experimental autoimmune neuritis in the Lewis rat.
Taylor JM; Pollard JD
Muscle Nerve; 2003 Sep; 28(3):344-52. PubMed ID: 12929195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
